MedDataX Logo

X-ray Dose Reduction Study for Cardiac Angiography and Intervention

NCT01684826 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-03-08

Study results available
· View outcomes & findings →

Summary

ClarityIQ is a novel X-ray imaging technology, that combines advanced real-time image noise reduction algorithms, with state-of-the-art hardware to reduce patient entrance dose significantly. This is realized by anatomy-specific optimization of the full acquisition chain (grid switch, beam filtering, pulse width, spot size, detector and image processing engine) for every clinical task individually. Furthermore, smaller focal spot sizes and shorter pulses are used, which are known to positively influence image quality . The final effect on the clinical image quality is investigated in this study.

Conditions

  • Vascular Diseases

Interventions

RADIATION

Angiographic run with new algorithm and low dose (50% dose)

Angiographic run with new algorithm and low dose (50% lower dose compared to Xper)

RADIATION

Angiographic run with predecessor algorithm and dose (100%)

Angiographic run with predecessor algorithm and dose (100% dose)

Sponsors & Collaborators

  • Philips Clinical & Medical Affairs Global

    lead INDUSTRY

Principal Investigators

  • Harry Suryapranata, Prof Dr. · Radboud University Nijmegen Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • Netherlands

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01684826 on ClinicalTrials.gov